AI-Driven Comprehensive SERS-LFIA System: Improving Virus Automated Diagnostics Through SERS Image Recognition and Deep Learning.

Publication date: Jul 16, 2025

Highly infectious and pathogenic viruses seriously threaten global public health, underscoring the need for rapid and accurate diagnostic methods to effectively manage and control outbreaks. In this study, we developed a comprehensive Surface-Enhanced Raman Scattering-Lateral Flow Immunoassay (SERS-LFIA) detection system that integrates SERS scanning imaging with artificial intelligence (AI)-based result discrimination. This system was based on an ultra-sensitive SERS-LFIA strip with SiO-Au NSs as the immunoprobe (with a theoretical limit of detection (LOD) of 1. 8 pg/mL). On this basis, a negative-positive discrimination method combining SERS scanning imaging with a deep learning model (ResNet-18) was developed to analyze probe distribution patterns near the T line. The proposed machine learning method significantly reduced the interference of abnormal signals and achieved reliable detection at concentrations as low as 2. 5 pg/mL, which was close to the theoretical Raman LOD. The accuracy of the proposed ResNet-18 image recognition model was 100% for the training set and 94. 52% for the testing set, respectively. In summary, the proposed SERS-LFIA detection system that integrates detection, scanning, imaging, and AI automated result determination can achieve the simplification of detection process, elimination of the need for specialized personnel, reduction in test time, and improvement of diagnostic reliability, which exhibits great clinical potential and offers a robust technical foundation for detecting other highly pathogenic viruses, providing a versatile and highly sensitive detection method adaptable for future pandemic prevention.

Open Access PDF

Concepts Keywords
Basel Artificial Intelligence
Immunoprobe automated detection system
Pandemic Biosensing Techniques
Rapid Deep Learning
Viruses deep learning
Gold
Gold
Humans
Immunoassay
Limit of Detection
machine learning
Metal Nanoparticles
SARS-CoV-2
SERS-LFIA
Spectrum Analysis, Raman
Viruses

Semantics

Type Source Name
disease IDO process
disease MESH Middle East respiratory syndrome
disease MESH COVID 19
disease MESH morbidity
pathway REACTOME Signal Transduction
pathway REACTOME Signal amplification
disease IDO assay
disease MESH anomalies
drug DRUGBANK Silver nitrate
drug DRUGBANK Ascorbic acid
drug DRUGBANK Sodium hydroxide
drug DRUGBANK Tromethamine
drug DRUGBANK Povidone K30
drug DRUGBANK Edetic Acid
drug DRUGBANK Phosphate ion
disease MESH Influenza
drug DRUGBANK Sodium Citrate
drug DRUGBANK Gold
drug DRUGBANK Silicon dioxide
drug DRUGBANK Water
drug DRUGBANK Ethanol
disease MESH immobilization
disease IDO reagent
disease MESH residual block
drug DRUGBANK Flunarizine
drug DRUGBANK Tretamine
drug DRUGBANK Isoxaflutole
drug DRUGBANK Saquinavir
disease MESH confusion
drug DRUGBANK Activated charcoal
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Hydrogen peroxide
drug DRUGBANK Chloramphenicol
disease IDO cell
drug DRUGBANK Guanosine
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Selenium

Original Article

(Visited 1 times, 1 visits today)